SEARCH

SEARCH BY CITATION

References

  • Carter, P.J. (2006) Potent antibody therapeutics by design. Nature Reviews Immunology, 6, 343357.
  • Imada, K., Takaori-Kondo, A., Sawada, H., Imura, A., Kawamata, S., Okuma, M. & Uchiyama, T. (1996) Serial transplantation of adult T cell leukemia cells into severe combined immunodeficient mice. Japanese Journal of Cancer Research, 87, 887892.
  • Ishida, T. & Ueda, R. (2006) CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Science, 97, 11391146.
  • Ishida, T., Utsunomiya, A., Iida, S., Inagaki, H., Takatsuka, Y., Kusumoto, S., Takeuchi, G., Shimizu, S., Ito, M., Komatsu, H., Wakita, A., Eimoto, T., Matsushima, K. & Ueda, R. (2003) Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma (ATLL): its close association with skin involvement and unfavorable outcome. Clinical Cancer Research, 9, 36253634.
  • Ishida, T., Iida, S., Akatsuka, Y., Ishii, T., Miyazaki, M., Komatsu, H., Inagaki, H., Okada, N., Fujita, T., Shitara, K., Akinaga, S., Takahashi, T., Utsunomiya, A. & Ueda, R. (2004) The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma. Clinical Cancer Research, 10, 75297539.
  • Ishida, T., Ishii, T., Inagaki, A., Yano, H., Kusumoto, S., Ri, M., Komatsu, H., Iida, S., Inagaki, H. & Ueda, R. (2006) The CCR4 as a novel specific molecular target for immunotherapy in Hodgkin lymphoma. Leukemia, 20, 21622168.
  • Niwa, R., Shoji-Hosaka, E., Sakurada, M., Shinkawa, T., Uchida, K., Nakamura, K., Matsushima, K., Ueda, R., Hanai, N. & Shitara, K. (2004) Defucosylated chimeric anti-CCR4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma. Cancer Research, 64, 21272133.
  • Taylor, G.P. & Matsuoka, M. (2005) Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene, 24, 60476057.
  • Uchida, J., Hamaguchi, Y., Oliver, J.A., Ravetch, J.V., Poe, J.C., Haas, K.M. & Tedder, T.F. (2004) The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. The Journal of Experimental Medicine, 199, 16591669.
  • Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. & Uchino, H. (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood, 50, 481492.